Durham University
13
1
1
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
7.7%
1 terminated/withdrawn out of 13 trials
75.0%
-11.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (13)
Implementation Facilitation of Exercise is Medicine Greenville
Role: collaborator
Feasibility and Effects of Home-based Physical Activity Intervention in Patients With Breast Cancer in Indonesia
Role: collaborator
Implementing and Evaluating the Integration of Physical Activity Into a Major Health System and Connecting Patients to Physical Activity Programs.
Role: collaborator
Carcinoma of Unknown Primary (CUP): a Comparison Across Tissue and Liquid Biomarkers
Role: collaborator
Visual Perception Difficulties After Stroke
Role: lead
VISION: Triple Negative Breast Cancer Sample and Clinical Data Acquisition Study
Role: collaborator
PANenteric Crohn's Capsule Versus Ileo-Colonoscopy and Scan Study
Role: collaborator
Terahertz Metamaterials for Tumour Marker Concentration Identification
Role: lead
Exercise Intervention in Primary Open-angle Glaucoma
Role: collaborator
Sex Differences in Muscle Damage Following Resistance Exercise at Low or High Intensity
Role: lead
Sex Differences in Muscle Damage Following Resistance Exercise With or Without Milk Protein Ingestion
Role: lead
Canine COVID-19 Detection Phase 2 and 3
Role: collaborator
Canine COVID-19 Detection
Role: collaborator
All 13 trials loaded